Perbandingan Angka Kematian Terapi Antiviral Favipiravir dan Remdesivir pada Pasien COVID-19 Di RSUP Dr. Sardjito Yogyakarta

Perbandingan Angka Kematian Terapi Antiviral Favipiravir dan Remdesivir pada Pasien COVID-19 Di RSUP Dr. Sardjito Yogyakarta

Antiviral treatment for SARS-CoV2 (Severe Acute Respiratory Syndrome Coronavirus-2) is still being studied for its effectivity. The antivirals in the July 3, 2021 edition of the COVID-19 management guidelines, namely favipiravir and remdesivir, are used for moderate, severe and critical degrees. The...

Full description

Bibliographic Details
Main Authors: Nova Satriyani, Fita Rahmawati, Tri Murti Andayani
Format: Article
Language:Indonesian
Published: Universitas Gadjah Mada 2023-01-01
Series:Jurnal Manajemen dan Pelayanan Farmasi
Subjects:
covid-19
favipiravir
mortality
remdesivir
Online Access:https://jurnal.ugm.ac.id/jmpf/article/view/77288

Internet

https://jurnal.ugm.ac.id/jmpf/article/view/77288

Similar Items